Osteoarthritis

Modification of cardiovascular risk factors after viscosupplementation with hyaluronic acid in patients with symptomatic hip and knee osteoarthritis

Clin Exp RheumatolPublished Retrospective cohort study

Authors' conclusion

Intra-articular viscosupplementation with hyaluronic acid in symptomatic hip and knee osteoarthritis achieves a decrease in pain, potentially allowing patients to increase their physical activity levels, which helps control weight and BMI.

Study context

Population
Patients with symptomatic hip and knee OA meeting ACR clinical and radiological criteria, Kellgren-Lawrence grades I–IV
Participants
101 patients
Exposure
Before vs after four intra-articular hyaluronic acid injections
Outcome
Modification of cardiovascular risk factor parameters after intra-articular hyaluronic acid injection

Main finding

As reported in the abstract

Modification of CV risk factor parameters after intra-articular hyaluronic acid · 24 months
Reduction in pain (VAS), points
1.2 (p<0.001)
Increase in physical activity
19.81% (p<0.001)
Increase in physical activity frequency
21.8% (p=0.001)
Significant decrease in total cholesterol in patients with pathological baseline levels
p=0.002
Significant decrease in LDL in patients with pathological baseline levels
p=0.009
Significant decrease in HDL in patients with pathological baseline levels
p=0.023
Significant decrease in triglycerides in patients with pathological baseline levels
p=0.021

Observational data: associations, not effects.

Further findings

Lipid parameters in patients with pathological baseline levels

Total cholesterol: significant decrease
P = 0.002
LDL: significant decrease
P = 0.009
HDL: significant decrease
P = 0.023
Triglycerides: significant decrease
P = 0.021

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Modification of cardiovascular risk factors after viscosupplementation with hyaluronic acid in patients with symptomatic hip and knee osteoarthritis. Clin Exp Rheumatol. Published 1 April 2025. doi:10.55563/clinexprheumatol/tsa1u8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.